TEMASEK HOLDINGS LTD 13D and 13G filings for Beam Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-06 07:27 am Sale |
2023-12-31 | 13G | Beam Therapeutics Inc. BEAM |
TEMASEK HOLDINGS LTD | 3,076,117 3.800% |
-568,456 (-15.60%) |
Filing |
| 2023-03-17 06:04 am Purchase |
2023-03-09 | 13G | Beam Therapeutics Inc. BEAM |
TEMASEK HOLDINGS LTD | 3,644,573 5.000% |
766,276 (+26.62%) |
Filing |
| 2023-02-10 06:10 am Sale |
2022-12-31 | 13G | Beam Therapeutics Inc. BEAM |
TEMASEK HOLDINGS LTD | 2,878,297 4.100% |
-1,080,915 (-27.30%) |
Filing |
| 2022-02-14 06:38 am Purchase |
2021-12-31 | 13G | Beam Therapeutics Inc. BEAM |
TEMASEK HOLDINGS LTD | 3,959,212 5.800% |
604,571 (+18.02%) |
Filing |
| 2021-02-05 06:06 am Purchase |
2020-02-06 | 13G | Beam Therapeutics Inc. BEAM |
TEMASEK HOLDINGS LTD | 3,354,641 5.700% |
3,354,641 (New Position) |
Filing |